Read More Pharma Industry News Hyloris Pharmaceuticals buys global rights to CRD-102 from Baker Institute Hyloris Pharmaceuticals has acquired the global rights from Australia-based Baker Heart and Diabetes Institute (Baker Institute) to CRD-102,… bySrinathOctober 8, 2021
